Visual tests predict dementia risk in Parkinson disease
Louise-Ann Leyland1, Fion D Bremner1, Ribeya Mahmood1
1Dementia Research Centre (L-AL, RM, RSW), Institute of Neurology, University College London, United Kingdom; Neuro-ophthalmology (FDB, MM-ML), National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, United Kingdom; Institute of Neurology (SH, MD, MREC), University College London, UCL, United Kingdom; School of Biomedical Sciences (MREC), Biological Sciences, Leeds University, United Kingdom; ImpAct (LEM), Lyon Neuroscience Research Center, France; Department of Cognitive Science (APS), University of California, San Diego; Kavli Institute for Brain and Mind (APS), University of California, San Diego; Institute of Ophthalmology (PAK), UCL, United Kingdom; Moorfields Eye Hospital (PAK), London, United Kingdom; Department of Clinical Neuroscience (AES), Institute of Neurology, UCL Hampstead Campus, London, United Kingdom; Movement Disorders Consortium (AES, RSW), UCL, United Kingdom; and The Wellcome Centre for Human Neuroimaging (RSW), Institute of Neurology, University College London, United Kingdom.
Visual impairments and thinning of specific retinal layers may predict dementia risk in Parkinson disease (PD). These findings suggest potential biomarkers for early detection of PD dementia.
Area of Science:
- Ophthalmology
- Neurology
- Neuroscience
Background:
- Parkinson disease (PD) is a neurodegenerative disorder with a significant risk of developing dementia.
- Early identification of individuals at risk for PD dementia is crucial for timely intervention.
- Visual dysfunction and retinal changes have been anecdotally linked to PD progression.
Purpose of the Study:
- To investigate the predictive value of visual measures and retinal volume for the risk of dementia in Parkinson disease.
- To explore the association between specific retinal layers and the risk of developing PD dementia.
Main Methods:
- A cohort study involving individuals with PD and age-matched controls.
- Ophthalmic examinations, including visual acuity, contrast sensitivity, skew tolerance, and biological motion perception.
- Retinal imaging using optical coherence tomography (OCT) to measure retinal layer volumes, specifically the ganglion cell layer (GCL) and inner plexiform layer (IPL).
- Assessment of PD dementia risk using a validated algorithm incorporating clinical and demographic factors.
Main Results:
- Poorer performance in visual tests (acuity, contrast sensitivity, skew tolerance, biological motion) was significantly associated with a higher risk of PD dementia.
- Thinner retinal GCL and IPL volumes, layers containing dopaminergic cells, were correlated with an increased risk of PD dementia.
- No significant associations were found in the retinal nerve fiber layer (lacking dopaminergic cells) or in unaffected controls.
Conclusions:
- Visual measures and retinal structure, particularly in dopaminergic cell-containing layers (GCL and IPL), are related to the risk of dementia in Parkinson disease.
- Retinal GCL and IPL volumes, along with visual assessments, show potential as non-invasive biomarkers for predicting dementia risk in PD.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...


